Switching from Adderall 10mg Twice Daily to Adderall XR
Switch directly to Adderall XR 20 mg once daily in the morning, which is the bioequivalent total daily dose. 1
Direct Conversion Based on Total Daily Dose
The FDA label explicitly states that patients taking divided doses of immediate-release Adderall (such as twice daily) may be switched to Adderall XR at the same total daily dose taken once daily 1. Since your patient is currently taking 10 mg twice daily (total 20 mg/day), the appropriate conversion is:
- Current regimen: Adderall IR 10 mg BID = 20 mg total daily
- New regimen: Adderall XR 20 mg once daily upon awakening
This conversion is supported by bioequivalence data showing that a single dose of Adderall XR 20 mg provides comparable plasma concentration profiles of both d-amphetamine and l-amphetamine to Adderall IR 10 mg twice daily administered 4 hours apart 1.
Administration Details
Timing and administration:
- Give Adderall XR upon awakening 1
- Avoid afternoon doses due to insomnia risk 1
- May be taken with or without food (though high-fat meals delay Tmax by ~2.5 hours without affecting total absorption) 1
- Capsules may be swallowed whole OR opened and sprinkled on applesauce if swallowing is difficult 1
Pharmacokinetic Rationale
The extended-release formulation contains immediate-release beads (releasing the first half of the dose upon ingestion) and delayed-release beads (releasing approximately 4 hours later) 2. This design:
- Provides onset of action within 1.5 hours 2
- Achieves Tmax at approximately 7 hours (versus 3 hours for IR) 1
- Delivers 12-hour symptom coverage 3
- Maintains the same 3:1 ratio of dextroamphetamine to levoamphetamine as IR formulation 1
Post-Switch Monitoring
After switching, titrate at weekly intervals if needed based on efficacy and tolerability 1. For adults, the FDA-approved dosing range is 20 mg/day (starting dose when switching from another medication), though doses can be adjusted based on response 1.
Key monitoring points:
- Assess symptom control throughout the day (particularly late afternoon/evening coverage)
- Monitor for insomnia (most common adverse effect at 36.5%) 4
- Check for appetite suppression/anorexia (21.2% incidence) 4
- Evaluate cardiovascular parameters (pulse and blood pressure) 4
Common Pitfalls to Avoid
- Do not start at a lower dose unless there are specific tolerability concerns—the bioequivalence data supports direct 1:1 total daily dose conversion 1
- Do not split the XR dose throughout the day—it is designed for once-daily administration 1
- Do not divide capsule contents—patients must take the entire capsule contents, not partial doses 1
- Do not give late in the day—this increases insomnia risk significantly 1
The switch is straightforward and well-supported by both FDA labeling and pharmacokinetic studies demonstrating bioequivalence at matched total daily doses 1.